The global DNA extraction kits market size was USD 1.2 Billion in 2022 and is likely to reach USD 2.21 Billion by 2031, expanding at a CAGR of 7% during the forecast period 2023–2031. Rising demand for automation in DNA extraction techniques and the development of user-friendly kits are fueling the market.
Increasing use of DNA extraction kits for profiling different micro organisms, which cause viral diseases and infections, is fueling the market. These kits aid in examining and tracking microorganisms efficiently, which encourages researchers & scientists to formulate drugs and medicines for advanced strains of diseases and viruses.
Growing investments in research & development for different disease detection aspects such as molecular diagnostics and infectious diseases diagnostics are propelling the DNA extraction kits market. A DNA extraction kit offers a simple and non-toxic setup for high-molecular-weight DNA isolation from a tissue, blood, or cultured cells.
These kits are preferred in healthcare facilities, as they eliminate the use of phenol or chloroform, and allow for completion of the extraction process in around two to three hours, which is shorter than conventional extraction methods.
The market report finds that the COVID-19 pandemic led to a sudden boost in the demand for DNA extraction kits, due to high scope of the development of nucleic acid extraction kits for corona virus-infected patients.
COVID-19 is a novel disease, hence, several scientists were working on finding solutions for diagnosing and curing the infection. This gave rise to the launch of different RNA & DNA testing and extraction kits during the pandemic.
DNA Extraction Kits Market Dynamics
Major Drivers
Rising prevalence of chronic diseases is one of the significant drivers of the market. It is increasing the demand for advanced DNA testing and extraction kits. Chronic diseases are a major cause of death and disabilities globally. DNA testing kits make it possible to extract tumor DNA, which is used for genetic testing.
-
According to World Health Organization (WHO), in 2020, around 10 million deaths were caused, due to cancer. Breast cancer, lung cancer, colorectum cancer, and prostate cancer were identified as most commonly occurring cancer. Several cancers are treated and cured if they are detected early.
Rising investment in the development of molecular diagnostics for the identification & treatment of different diseases is likely to propel the market in the coming years. Additionally, the increasing use of DNA extraction methods for predictive genetic testing and prenatal diagnosis is likely to boost the market. Adoption of advanced technology and kits is enabling rapid prenatal screening and testing of genetic abnormalities in newborns.
Existing Restraints
Lack of expert personnel for handling complex DNA extraction kits for isolating nucleic acids in forensic setups is expected to restrain the market. Shortage of resources for extraction technology in developing countries impedes the growth of the market.
Additionally, strict regulations associated with DNA extraction technology and the high cost associated with the kits are projected to affect the market in the coming years.
Emerging Opportunities
Development of vaccines to treat & prevent different diseases is expected to create opportunities in the market. Researchers are focusing on establishing and growing their training & research networks with different institutes. Such developments in the research help major players to launch products according to updated end-user requirements, thus, creating potential for market expansion.
Increasing government funding and support for the progress & development of DNA extraction procedures is anticipated to create opportunities in the market. Furthermore, the growing emphasis on next-generation sequencing (NGS) and DNA extraction technology is projected to create lucrative opportunities for manufacturers in the market.
Scope of DNA Extraction Kits Market Report
The report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
DNA Extraction Kits Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Product (Genomic DNA, Cell-free DNA, and Others), Sample Type (Blood, Formalin-Fixed Paraffin-Embedded, Tissue, and Others), Type (Column-Based, Magnetic Bead-Based, and Others), Application (Genomics, Diagnostics, Drug Discovery, and Others), and End-user (Hospitals, Diagnostic Centers, Research Institutes, Biotechnology Companies, and Others)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Shanghai Henlius Biotech, Inc.; Thermo Fisher Scientific Inc.; Bio-Rad Laboratories, Inc.; Promega Corporation; Evotec SE; QIAGEN; F. Hoffmann-La Roche Ltd; Agilent Technologies Inc.; BIONEER CORPORATION; and Merck KGaA
|
DNA Extraction Kits Market Segment Insights
Product Segment Analysis
On the basis of product, the DNA extraction kits market is segregated into genomic DNA, cell-free DNA, and others. The cell-free DNA (cf DNA) segment is projected to expand at a considerable CAGR during the forecast period, as it helps in focusing on the production of protein.
Analyzing and isolating cf DNA from serum, urine, or plasma sample by using cf DNA extraction kits is a non-invasive method to monitor & detect targets associated with a particular disease such as cancer. Thus, the increasing demand for cf DNA extraction kits is anticipated to boost the segment.
The genomic DNA segment accounts for a significant market share, due to consistent investments in genomic studies and personalized medicines. These kits are easy to use and are available in affordable price ranges. These features of the genomic DNA kits drive the segment.
Sample Type Segment Analysis
Based on sample type, the market is divided into blood, Formalin-Fixed Paraffin-Embedded (FFPE), tissue, and others. The blood segment is projected to expand at a high growth rate during the forecast period, as it is the most preferred source in DNA sampling. Blood contains a high amount of DNA & RNA, which makes it a rich source for an effective DNA extraction process, which further propels the segment.
The tissue segment is anticipated to account for a significant market share during the forecast period, due to developments in next-generation sequencing methods. This technology is used in determining the sequence of nucleotides in the genomes or targeted RNA or DNA location. Thus, such developments are projected to drive the segment.
Type Segment Analysis
Based on type, the market is divided into column-based, magnetic bead-based, and others. The magnetic bead-based segment is anticipated to expand at a significant growth rate during the forecast period, due to its rising adoption among scientists & researchers for enhanced purification & isolation of DNA.
Technology for automated extraction with less need for centrifugation of nucleic acid isolation procedures is gaining high popularity among researchers. Thus, functionalized magnet bead-based DNA extraction kits along with appropriate buffer systems are being used to minimize the need for centrifugation, as it breaks the nucleic acids. Ongoing developments in DNA-related research and development initiatives propel the segment.
The column-based segment is anticipated to account for a major market share during the forecast period, as it helps in obtaining quality nucleic acids in minimum time. Silica columns are highly preferred, as they offer desired benefits.
They are used in spin columns that have different benefits, such as high yield, instant results, and cost efficiency. Column-based kits are easily integrated with automated instruments; thus, they are widely adopted in DNA extraction technology, which, in turn boosts the segment.
Application Segment Analysis
On the basis of application, the DNA extraction kits market is segregated into genomics, diagnostics, drug discovery, and others. The diagnostics segment is projected to expand at a high CAGR during the forecast period, due to a surge in the prevalence of genetic disorders, cancer, and chronic diseases in different countries. This increases the demand for DNA extraction kits, as it helps to determine and diagnose the severity of diseases and provide treatment at the right time.
Applications of DNA extraction kits in disease diagnosis help in formulating and improving proper medication, according to the requirement of the patient. This is likely to propel the segment.
The genomics segment accounts for a significant market share, due to the rising awareness among individuals regarding genomic diagnostics and its benefits. Applying DNA extraction tools for genomic technology helps in increasing the efficiency of the genomic sequencing process.
Furthermore, this high efficacy helps in diagnosing diseases accurately and creating personalized medicines for improving health conditions, which, in turn, boosts the segment. For instance,
End-user Segment Analysis
On the basis of end-user, the market is segmented into hospitals, diagnostic centers, research institutes, biotechnology companies, and others. The diagnostic centers segment is expected to expand at a robust growth rate during the forecast period, owing to the increasing demand for DNA extraction kits among diagnostic laboratories, for characterizing and identifying microbes.
Certain microbes are the prominent cause of several chronic diseases, thus diagnostic centers use extraction kits to identify them. This factor propels the segment. The biotechnology companies segment is expected to hold a significant share of the market, due to the increasing sample testing activities for different genetic disorders.
Rising cases of different types of cancer and the increasing need for medication and drug development are boosting the demand for extraction kits in the biotechnology sector. These kits assist companies and professionals in carrying out genome sequencing, forensic science, genetic engineering for animals & plants, and bacteria & virus detection. Thus, these benefits are likely to propel the segment.
Regional Outlook
In terms of region, the global DNA extraction kits market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the forecast period, due to the increasing R&D activities in the region.
Market players in North America are focusing on product launches and improving their portfolios, which is expected to help in the market expansion. Growing investments of the private sector and governments in improving genetic engineering technology is further propelling the regional market.
Additionally, the increasing frequency of chronic conditions among people in North America fuels the demand for DNA extraction kits in the region. For instance,
-
According to research by the American Cancer Society (ACS), the number of new cancer cases in the US was estimated to be around 1.9 million in 2022. Out of these, about 6,09,360 deaths were caused, due to different types of cancer.
The market in Europe is anticipated to expand at a rapid pace during the forecast period, which is attributed to the supportive government policies and the rising patient population in Europe. Suitable government initiatives are being implemented for improving the present conditions of patients with chronic conditions. These aspects are projected to give rise to R&D activities for the development and production of extraction kits and their quality control measures.
Segments
The DNA extraction kits market has been segmented on the basis of
Product
- Genomic DNA
- Cell-free DNA
- Others
Sample Type
- Blood
- Formalin-Fixed Paraffin-Embedded (FFPE)
- Tissue
- Others
Type
- Column-Based
- Magnetic Bead-Based
- Others
Application
- Genomics
- Diagnostics
- Drug Discovery
- Others
End-user
- Hospitals
- Diagnostic Centers
- Research Institutes
- Biotechnology Companies
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
Competitive Landscape
Key players operating in the global DNA extraction kits market include Shanghai Henlius Biotech, Inc.; Thermo Fisher Scientific Inc.; Bio-Rad Laboratories, Inc.; Promega Corporation; Evotec SE; QIAGEN; F. Hoffmann-La Roche Ltd; Agilent Technologies Inc.; BIONEER CORPORATION; and Merck KGaA
These companies adopt strategies such as acquisitions, partnerships, collaboration, mergers, R&D investments, and product launches to boost their market share. For instance,
Request For Customization
Enquiry Before Buying
Speak With Analyst
